(Q34610680)

English

Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668123%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668123%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

based on heuristic

inferred from title

major depressive disorder

1 reference

based on heuristic

inferred from title

Susan G Kornstein

1

object named as

Susan G Kornstein

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668123%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Dayong Li

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668123%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Yongcai Mao

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668123%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Sara Larsson

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668123%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Henning F Andersen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668123%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

George I Papakostas

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668123%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668123%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

C N S Spectrums

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668123%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668123%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668123%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

326-333

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668123%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of baseline severity on efficacy of escitalopram and citalopram in the treatment of major depressive disorder: an extended analysis.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapy.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Depression, chronic diseases, and decrements in health: results from the World Health Surveys.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of effect size to determine optimal dose of duloxetine in major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Escitalopram versus venlafaxine XR in the treatment of depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020320

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S1092852900020320

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668123%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668123%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34610680&oldid=1957750963"